Key Record Dates
ClinicalTrials.gov Identifier: | NCT04994483 |
---|---|
Brief Title: | Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease (RETHINK-ALZ) |
First Submitted : | July 29, 2021 |
First Submitted that Met QC Criteria : | July 29, 2021 |
First Posted : | August 6, 2021 |
Last Update Submitted that Met QC Criteria : | January 25, 2024 |
Last Update Posted : | January 26, 2024 |